Cargando…
Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China
BACKGROUND: Both breast-conserving surgery and breast reconstruction surgery are less popular in China, although they can improve patients’ quality of life. The main reason comes from the economy. There is currently no economic evaluation of different surgical treatment options for early breast canc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856742/ https://www.ncbi.nlm.nih.gov/pubmed/33530955 http://dx.doi.org/10.1186/s12885-021-07840-6 |
_version_ | 1783646305368670208 |
---|---|
author | Yang, Qing Zhong, Xiaorong Zhang, Wei Luo, Ting He, Ping Zheng, Hong |
author_facet | Yang, Qing Zhong, Xiaorong Zhang, Wei Luo, Ting He, Ping Zheng, Hong |
author_sort | Yang, Qing |
collection | PubMed |
description | BACKGROUND: Both breast-conserving surgery and breast reconstruction surgery are less popular in China, although they can improve patients’ quality of life. The main reason comes from the economy. There is currently no economic evaluation of different surgical treatment options for early breast cancer. Our study aims to assess the economic impact and long-term cost-effectiveness of different surgical treatments for early breast cancer. The surgical approaches are including mastectomy (MAST), breast-conserving therapy (BCT), and mastectomy with reconstruction (MAST+RECON). METHODS: Based on demographic data, disease-related information and other treatments, we applied propensity score matching (PSM) to perform 1: 1 matching among patients who underwent these three types of surgery in the tertiary academic medical center from 2011 to 2017 to obtain a balanced sample of covariates between groups. A Markov model was established. Clinical data and cost data were obtained from the medical records. Health utility values were derived from clinical investigations. Strategies were compared using an incremental cost-effectiveness ratio (ICER). RESULTS: After PSM, there were 205 cases in each group. In the matched data set, the distribution of covariates was fully balanced. The total cost of MAST, MAST+RECON and BCT was $37,392.84, $70,556.03 and $82,330.97, respectively. The quality-adjusted life year (QALYs) were 17.11, 18.40 and 20.20, respectively. Compared with MAST, MAST+RECON and BCT have an ICER of $25,707.90/QALY and $14,543.08/QALY, respectively. The ICER of BCT vs. MAST was less than the threshold of $27,931.04. The reliability and stability of the results were confirmed by Monte Carlo simulation and sensitivity analysis. CONCLUSIONS: We believe that in the context of the limited resources in China, after comparing the three surgical approaches, BCT is the more cost-effective and preferred solution. |
format | Online Article Text |
id | pubmed-7856742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78567422021-02-04 Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China Yang, Qing Zhong, Xiaorong Zhang, Wei Luo, Ting He, Ping Zheng, Hong BMC Cancer Research Article BACKGROUND: Both breast-conserving surgery and breast reconstruction surgery are less popular in China, although they can improve patients’ quality of life. The main reason comes from the economy. There is currently no economic evaluation of different surgical treatment options for early breast cancer. Our study aims to assess the economic impact and long-term cost-effectiveness of different surgical treatments for early breast cancer. The surgical approaches are including mastectomy (MAST), breast-conserving therapy (BCT), and mastectomy with reconstruction (MAST+RECON). METHODS: Based on demographic data, disease-related information and other treatments, we applied propensity score matching (PSM) to perform 1: 1 matching among patients who underwent these three types of surgery in the tertiary academic medical center from 2011 to 2017 to obtain a balanced sample of covariates between groups. A Markov model was established. Clinical data and cost data were obtained from the medical records. Health utility values were derived from clinical investigations. Strategies were compared using an incremental cost-effectiveness ratio (ICER). RESULTS: After PSM, there were 205 cases in each group. In the matched data set, the distribution of covariates was fully balanced. The total cost of MAST, MAST+RECON and BCT was $37,392.84, $70,556.03 and $82,330.97, respectively. The quality-adjusted life year (QALYs) were 17.11, 18.40 and 20.20, respectively. Compared with MAST, MAST+RECON and BCT have an ICER of $25,707.90/QALY and $14,543.08/QALY, respectively. The ICER of BCT vs. MAST was less than the threshold of $27,931.04. The reliability and stability of the results were confirmed by Monte Carlo simulation and sensitivity analysis. CONCLUSIONS: We believe that in the context of the limited resources in China, after comparing the three surgical approaches, BCT is the more cost-effective and preferred solution. BioMed Central 2021-02-02 /pmc/articles/PMC7856742/ /pubmed/33530955 http://dx.doi.org/10.1186/s12885-021-07840-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Yang, Qing Zhong, Xiaorong Zhang, Wei Luo, Ting He, Ping Zheng, Hong Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China |
title | Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China |
title_full | Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China |
title_fullStr | Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China |
title_full_unstemmed | Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China |
title_short | Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China |
title_sort | cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from china |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856742/ https://www.ncbi.nlm.nih.gov/pubmed/33530955 http://dx.doi.org/10.1186/s12885-021-07840-6 |
work_keys_str_mv | AT yangqing costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina AT zhongxiaorong costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina AT zhangwei costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina AT luoting costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina AT heping costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina AT zhenghong costeffectivenessofdifferentsurgicaltreatmentapproachesforearlybreastcanceraretrospectivematchedcohortstudyfromchina |